Oesophageal cancer, Stomach cancer
Results
Phase 3
This trial looked at the combination of onartuzumab and chemotherapy. It was for people with either:
stomach cancer, or
cancer in the area where the food pipe (oesophagus) meets the stomach – the gastro oesophageal junction
It was for people whose cancer had spread to another part of the body and who had only small amounts of a protein called HER2. This is called .
The trial was open for people to join between 2012 and 2014. The team published the results in 2017.
Recruitment start: 13 December 2012
Recruitment end: 22 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cunningham
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 21 September 2023
CRUK internal database number: 9937
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
